Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

Share "Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation"

N/A

Protected

Studieår: 2022

Info

Nedlasting

Protected

Academic year: 2022

Share "Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation"

Copied!

Laster.... (Se fulltekst nå)

Last ned nå ( 11 sider )

Fulltekst

Referanser

Last ned nå ( PDF - 11 sider - 255.19 KB )

RELATERTE DOKUMENTER

Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3– Internal Tandem Duplication Mutation (SORMAIN)

$Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial$

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

TYRO3Truncation Resulting From a t(10;15)(p11;q15) Chromosomal Translocation in Pediatric Acute Myeloid Leukemia

Molecular Genetic Characterization of Acute Myeloid Leukemia With Trisomy 4 as the Sole Chromosome Abnormality

Additional File 1. Clinical and biological characteristics of acute myeloid leukemia patients ___________________________________________________________________________________________________________________________